Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4017362 | 0.75 | KDM4E (0.34) | ALDH1A1MAPTKDM4ELMNAGAA | |
| SCHEMBL28040791 | 0.68 | MEN1 (0.33) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL78887 | 0.67 | HTT (0.43) | ALDH1A1MAPTKDM4ELMNAGAA | |
| Ammonia Solution, Strong SCHEMBL79641 | 0.63 | — | — | |
| SCHEMBL79391 | 0.63 | ALDH1A1 (0.44) | ALDH1A1MAPTKDM4EGAATDP1 | |
| SCHEMBL9848292 | 0.62 | ALDH1A1 (0.50) | ALDH1A1MAPTKDM4ELMNAGAA | |
| SCHEMBL317299 | 0.60 | RAPGEF4 (0.50) | ALDH1A1MAPTKDM4ELMNAGAA | |
| SCHEMBL360400 | 0.60 | ALDH1A1 (0.56) | ALDH1A1MAPTKDM4ELMNAGAA | |
| SCHEMBL29568340 | 0.60 | ALDH1A1 (0.56) | ALDH1A1MAPTKDM4ELMNAGAA | |
| SCHEMBL394778 | 0.60 | ALDH1A1 (0.56) | ALDH1A1MAPTKDM4ELMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129488-B2 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2012-03-06 | — | — | US | disclosed |
| US-20090209712-A1 | TRANSITION METAL COMPLEXES, CATALYST COMPOSITIONS CONTAINING THE SAME, AND OLEFIN POLYMERIZATION USING THE CATALYST COMPOSITIONS | LG CHEM., LTD. (KR) | 2009-08-20 | — | — | US | disclosed |
| US-7538239-B2 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2009-05-26 | — | — | US | disclosed |
| US-7531608-B2 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2009-05-12 | — | — | US | disclosed |
| WO-2007007991-A1 | TRANSITION METAL COMPLEXES, CATALYST COMPOSITIONS CONTAINING THE SAME, OLEFIN POLYMERIZATION USING THE CATALYST COMPOSITIONS | LG CHEM, LTD. (KR) | 2007-01-18 | — | — | WO | disclosed |
| WO-2007007992-A1 | TRANSITION METAL COMPLEXES, CATALYST COMPOSITIONS CONTAINING THE SAME, AND OLEFIN POLYMERIZATION USING THE CATALYST COMPOSITIONS | LG CHEM, LTD. (KR) | 2007-01-18 | — | — | WO | disclosed |
| US-20070010638-A1 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2007-01-11 | — | — | US | disclosed |
| US-20070010637-A1 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010638-A1 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | CPNE4, AOC2, ODC1 | ALDH1A1 4020/4885MAPT 716/4885KDM4E 2895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.